John Kenneth Jenkins's Net Worth
$184 Thousand
Who is John Kenneth Jenkins?
John Kenneth Jenkins does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Provention Bio, Inc., and Corbus Pharmaceuticals Holdings, Inc..
SEC CIK
John Kenneth Jenkins's CIK is 0001742557
Past Insider Trading and Trends
2021 was John Kenneth Jenkins's most active year for acquiring shares with 3 total transactions. John Kenneth Jenkins's most active month to acquire stocks was the month of April. 2023 was John Kenneth Jenkins's most active year for disposing of shares, totalling 3 transactions. John Kenneth Jenkins's most active month to dispose stocks was the month of March. 2019 saw John Kenneth Jenkins paying a total of $6,977.90 for 34,300 shares, this is the most they've acquired in one year. In 2023 John Kenneth Jenkins cashed out on 184,981 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Provention Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Snapshot price: $50.04
InvestorJohn Kenneth Jenkins owns 1,000 units of Common Stock which is worth $50,040.00 and 2,816 units of Common Stock, par value $0.0001 per share which is worth $140,912.64. From 2018 to 2024 John Kenneth Jenkins acquired a total of 3,783 shares in Corbus Pharmaceuticals Holdings, Inc. at a cost of $6,977.90.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8,433.33% | 2.78K |
—
|
—
| 2.82K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
∞
| 1K |
$6.98 | $6,977.90 | 1K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||